Welcome to the PRIORITY website.
The PRIORITY website is a platform for information sharing, mainly aimed for the partners of the PRIORITY Consortium.

The website also serves for storing and sharing project related data for which only partners of the PRIORITY Consortium have access.

The aim of the PRIORITY research project is to investigate the potential of therapeutic intervention with spironolacton guided by early detection of diabetic nephropathy based on urinary proteomics. Patients classified by urinary proteomics to be in high risk of developing nephropathy will be randomised to spironolactone or placebo to try to prevent or delay nephropathy from occurring.

The project will be carried out as a multicenter study involving 15 partners in Europe for 6 years, and is funded by the EU’s Seventh Framework Programme (FP7).

PRIORITY stands for:
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria.